BCYC - Bicycle Therapeutics plc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

635.3M

Cash

457M

Avg Qtr Burn

-21.27M

Short % of Float

6.48%

Insider Ownership

1.38%

Institutional Own.

87.99%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
BT8009 (Nectin-4) Details Solid tumor/s, Cancer, Urothelial cancer, Bladder cancer	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BT5528 (EphA2) Details Solid tumor/s, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BT7480 (Nectin-4 CD137, TICA) Details Solid tumor/s, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BT1718 (MT1-MMP) Details Non-small cell lung carcinoma, Solid tumor/s, Cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.